# Karyopharm Therapeutics Inc. — Form D

Karyopharm Therapeutics Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-08. The offering totals $165.0M, of which $165.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-12-08
- Form: D
- Accession: 0001503802-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $165.0M
- Amount sold: $165.0M
- Investors: 33
- Date of first sale: 2022-12-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466961

## Issuer

- Name: Karyopharm Therapeutics Inc.
- CIK: 0001503802
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 85 WELLS AVENUE, NEWTON, MA, 02459
- Phone: 617-658-0600

## Officers, directors & promoters (25)

| Name | Role | Location |
| --- | --- | --- |
| Garen G Bohlin | Director | Newton, MA |
| Barry E Greene | Director | Newton, MA |
| Peter G Honig | Director | Newton, MA |
| Mansoor Raza Mirza | Director | Newton, MA |
| Christy J Oliger | Director | Newton, MA |
| Deepika R Pakianathan | Director | Mountain View, CA |
| Richard Paulson | Director | Newton, MA |
| Chen R Schor | Director | Newton, MA |
| Sohanya Cheng | Executive Officer | Newton, MA |
| Michael Mano | Executive Officer | Newton, MA |
| Michael Mason | Executive Officer | Newton, MA |
| Stephen Mitchener | Executive Officer | Newton, MA |
| Richard Paulson | Executive Officer | Newton, MA |
| Stuart Poulton | Executive Officer | Newton, MA |
| Reshma Rangwala | Executive Officer | Newton, MA |
| Sharon Shacham | Executive Officer | TEL AVIV, L3 |
| Paul Brannelly | Executive Officer | Cambridge, MA |
| MICHAEL KAUFFMAN | Director | NEEDHAM, MA |
| MICHAEL KAUFFMAN | Executive Officer | NEEDHAM, MA |
| Alan Barber | Executive Officer | Wellesley, MA |
| Barry Raza Greene | Director | Natick, MA |
| Deepika E Pakianathan | Director | Natick, MA |
| Sharon E Shacham | Executive Officer | Natick, MA |
| Kenneth E Weg | Director | Natick, MA |
| Ronald DePinho | Director | Cambridge, MA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2013-08-01](https://search.stillhousedata.com/formd/0001503802-13-000004) | D | $19.0M | $19.0M |
| [2013-05-01](https://search.stillhousedata.com/formd/0001503802-13-000003) | D | $60.0M | $20.5M |
| [2010-11-05](https://search.stillhousedata.com/formd/0001503802-10-000001) | D | $20.8M | $700K |

## More

- [CIK 1503802 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1503802&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001503802-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.